Uncontrolled growth of cells in the prostate gland
Vivani Medical is developing a long-acting semaglutide implant to deliver GLP-1 therapy over months, potentially replacing injections. Novo Nordisk is evaluating the device to improve adherence and reduce weight regain, but regulatory and cost questions remain as trials proceed.
A national AIHW data report shows cervical cancer incidence is dropping sharply among Australian women aged 25–29, while cancers like bowel cancer rise in their 30s. Vaccination campaigns begun in 2007 and school-based programs contributed to a projected elimination threshold by 2035, though most cancers still affect those 50 and older.
Troy Jackson has won the Maine Democratic nomination to replace Graham Platner and will challenge incumbent Republican Sen. Susan Collins in November. Jackson has consolidated delegate support at a special convention in Bangor and is positioning a working‑class, progressive agenda while critics and Jewish voters express concern over his recent stances on Israel.
A UK NHS study indicates focal therapy provides durable long‑term cancer control for many prostate cancer patients, with just two of 3,477 men dying from prostate cancer a decade after treatment and lower side‑effects. The government is expanding access to more centres.
Scotland faces a maternity care crisis with hundreds of deaths in five years. An independent review is announced to inspect culture, rural services and safety, while calls grow for a broader safety remit.
The Oversight Project has released roughly three hours of audio and 117 pages of heavily redacted transcripts of Joe Biden’s 2016–17 interviews with his ghostwriter for Promise Me, Dad. The recordings, obtained during Special Counsel Robert Hur’s documents probe, show Biden discussing retained notes and at times struggling with dates and details; Republicans say the tapes prove decline, Biden calls the release political.
Athletes and patients have urged Downing Street to appoint a national brain cancer lead and boost research funding. The Rare Cancers Bill is seen as a step forward but not enough, with calls for faster action in light of Commonwealth Games coverage and ongoing treatment campaigns.
Hunter Biden has told the BBC that his fathers prostate cancer has metastasized further, reaching his bones and beyond. He has described the disease as painful and debilitating while saying the 83-year-old former president remains active publicly. Biden revealed the diagnosis in May 2025 and has been undergoing radiation and hormone therapy.
GLP-1 medications are being increasingly prescribed off-label to children aged 8–11 in the US, despite no FDA approval for under-12s. A NYU Langone study shows a dramatic rise in June 2026, while experts warn about long-term effects and the broader obesity crisis.
This week has seen several medical research and regulatory developments. Insilico Medicine has reported that its experimental drug rentosertib changed blood‑protein patterns that aging clocks read as three to four years younger in a small trial. Stanford teams have published studies showing they can grow hindbrain neurons separately and implant human cortical organoids into mice. The US health department has appointed permanent directors for three FDA centers.
The Celebrity Traitors has won best reality competition at the NTAs, with Alan Carr receiving a special recognition award. Paloma Faith staged a coffin entrance, while Carr reflected on the year’s achievements as the ceremony celebrated multiple categories.
The Independent reports Clarkson has announced remission after aggressive prostate cancer treatment with high-intensity ultrasound. He says he will continue checking annually, but he is choosing joy and life’s small pleasures. He also recently won a TV award for Clarkson’s Farm.